期刊
VACCINES
卷 10, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/vaccines10040510
关键词
neutralizing antibodies; COVID-19; SARS-CoV-2; serological test; immunoassay; lateral flow assay; lateral flow immunochromatography; sensitivity and specificity
资金
- University of Alicante [WENZHOU-OJABIO1-21T]
This study investigated the presence of neutralizing antibodies against SARS-CoV-2 among healthcare workers in a hospital in Alicante, Spain, and compared the efficiency of a rapid diagnostic test to an ELISA viral neutralization test. The rapid test demonstrated high specificity and sensitivity, and individuals immunized with the BioNTech/Pfizer vaccine maintained optimal levels of neutralizing antibodies after six months. The use of this rapid test could be a potential tool in population-based studies to detect antibody responses to vaccination and guide vaccination policies for high-risk populations.
The presence of neutralizing antibodies (NAbs) against SARS-CoV-2 represent a surrogate marker of immunologic protection in populations at high risk of infection such as healthcare workers caring for hospitalized patients with COVID-19. As recommended by CDC and the European CDC, the use of rapid diagnostic tests during population-based evaluations offers an opportunity to identify individuals with serologic evidence of natural infection or who have undergone vaccination. We carried out a cross-sectional study to assess the presence of neutralizing antibodies against SARS-CoV-2 among medical providers at an intensive care unit of a large referral hospital in Alicante, Spain. In addition, we tested for the presence of neutralizing antibodies compared to serum of uninfected individuals from a Biobank. We were also interested in evaluating the use of a rapid lateral flow immunochromatography (LFIC) test against a surrogate ELISA viral neutralization test (sVNT). This rapid test demonstrated a specificity of 1.000 95% CI (0.91-1.00) and the sensitivity of 0.987 95% CI (0.93-1.00). The negative predictive value was 95%. After six months, this rapid test demonstrated that those immunized with two doses of BioNTech/Pfizer vaccine, maintained optimal levels of neutralizing antibodies. We concluded that all Health Care Workers develop NAbs and the use of this rapid immunochromatographic test represents a potential tool to be used in population-based studies to detect serological antibody responses to vaccination. Vaccination policies could benefit from this tool to assess additional doses of vaccine or boosters among high-risk populations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据